Multiple Sclerosis and Related Disorders

Scope & Guideline

Exploring groundbreaking insights in multiple sclerosis.

Introduction

Welcome to your portal for understanding Multiple Sclerosis and Related Disorders, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2211-0348
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2012 to 2024
AbbreviationMULT SCLER RELAT DIS / Mult. Scler. Relat. Disord.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The journal 'Multiple Sclerosis and Related Disorders' focuses on advancing the understanding of multiple sclerosis (MS) and related conditions through innovative research and clinical studies. Its core aims are to provide a platform for disseminating high-quality research that addresses various aspects of MS, including its pathophysiology, treatment, and patient care.
  1. Clinical and Epidemiological Research:
    The journal emphasizes studies that explore the clinical characteristics, epidemiology, and natural history of multiple sclerosis, providing valuable insights into the disease's progression and factors influencing its course.
  2. Therapeutic Advances and Treatment Protocols:
    It covers research on the efficacy and safety of disease-modifying therapies (DMTs) and other treatment modalities, including novel therapies, their impact on quality of life, and management strategies for MS and related disorders.
  3. Neuroimmunology and Pathophysiology:
    Research on the underlying immunological mechanisms and neurobiological changes associated with MS is a key focus, aiming to enhance understanding of disease mechanisms and identify potential therapeutic targets.
  4. Patient-Reported Outcomes and Quality of Life:
    The journal prioritizes studies that assess patient-reported outcomes, including quality of life, mental health, and the psychosocial impacts of living with MS, emphasizing a holistic approach to patient care.
  5. Innovative Diagnostic Techniques:
    Research exploring advanced diagnostic tools and biomarkers for MS, including imaging techniques and laboratory assays, is highlighted to improve diagnostic accuracy and patient stratification.
  6. Multidisciplinary Approaches to Care:
    The journal promotes studies that investigate the effectiveness of multidisciplinary care models, including rehabilitation, physical therapy, and psychological support for MS patients.
The journal has seen significant growth in specific research themes that reflect current trends and emerging interests in the field of multiple sclerosis. This section outlines these trending areas, showcasing their relevance and potential impact on future research and clinical practice.
  1. Impact of COVID-19 on MS Patients:
    Research exploring the effects of COVID-19 on MS patients, including vaccine responses and disease management during the pandemic, has surged, reflecting the urgency of understanding this intersection.
  2. Telemedicine and Remote Care Models:
    There is a growing emphasis on studies evaluating telehealth interventions and their effectiveness in managing MS, driven by the need for accessible care during the pandemic.
  3. Neuropsychological and Cognitive Function Studies:
    Increased attention is being given to the assessment and management of cognitive impairment in MS patients, focusing on innovative interventions and understanding the neuropsychological aspects of the disease.
  4. Patient-Centered Care and Shared Decision-Making:
    Research highlighting the importance of patient perspectives, shared decision-making, and personalized care approaches is gaining traction, indicating a shift towards more holistic and inclusive treatment strategies.
  5. Biomarkers and Predictive Modeling:
    Emerging studies focusing on biomarkers, such as neurofilament light chains, and their role in predicting disease progression and treatment response are trending, reflecting advancements in precision medicine.
  6. Lifestyle Interventions and Holistic Approaches:
    There is an upward trend in research examining the impact of lifestyle factors, including diet and exercise, on MS symptom management and overall health outcomes, emphasizing a comprehensive approach to care.

Declining or Waning

While 'Multiple Sclerosis and Related Disorders' has maintained a broad focus, certain areas have seen a decline in emphasis in recent years. This section identifies these waning scopes, reflecting shifts in research priorities and emerging interests.
  1. Basic Science Research:
    There appears to be a declining focus on basic science studies that explore fundamental biological mechanisms of MS, as the journal increasingly prioritizes clinical and translational research.
  2. Historical Epidemiological Studies:
    Research focusing solely on historical epidemiological trends without contemporary relevance may be waning, as the journal shifts towards studies that provide actionable insights for current clinical practice.
  3. Single-Disorder Focus:
    There is a noticeable reduction in publications that focus exclusively on multiple sclerosis, with a growing trend towards comparative studies involving related disorders, such as neuromyelitis optica spectrum disorders.
  4. Pharmacovigilance Studies without Clinical Implications:
    Studies that examine adverse drug reactions in isolation, without linking findings to clinical outcomes or treatment strategies, have become less common.

Similar Journals

ACTA NEUROLOGICA SCANDINAVICA

Transforming Neurological Research into Practice
Publisher: WILEYISSN: 0001-6314Frequency: 12 issues/year

ACTA NEUROLOGICA SCANDINAVICA is a prestigious journal published by Wiley that has significantly contributed to the field of neurology and neuroscience since its inception in 1961. With a broad scope encompassing clinical and experimental research, this journal is esteemed for its rigorous peer-review process and high-quality publications. Located in the United Kingdom, it is recognized in the 2023 category quartiles as Q1 in Medicine (miscellaneous) and Q2 in both Neurology and Clinical Neurology, indicating its strong influence and relevance within the medical community. With an H-index demonstrating consistent citation impact, ACTA NEUROLOGICA SCANDINAVICA holds a Scopus rank of #86 out of 400 in Clinical Neurology, reflecting its contribution to advancing current knowledge and practice. Researchers, professionals, and students alike will find in this journal a valuable resource for the latest findings, discussions, and developments in understanding neurological disorders and treatments, furthering educational and clinical endeavors alike.

CURRENT OPINION IN NEUROLOGY

Empowering Researchers with Current Neurological Perspectives.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1350-7540Frequency: 6 issues/year

CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.

Aktualnosci Neurologiczne

Fostering Innovation in Neurological Research
Publisher: MEDICAL COMMUNICATIONSISSN: 1641-9227Frequency: 4 issues/year

Aktualnosci Neurologiczne is a renowned open-access journal dedicated to the field of neurology, published by Medical Communications. As a crucial platform for the dissemination of neurological research, it has been operational since 2005, fostering an inclusive environment for scientific discourse and innovation. With an ISSN of 1641-9227, the journal aims to bridge the gap between clinical practice and research, offering a diverse range of articles that cover the latest developments in neurological science. Although its coverage in Scopus was discontinued after 2017, the journal continues to maintain a robust archive of scholarly articles that contribute to understanding neurological disorders. Researchers, healthcare professionals, and students interested in the latest trends and studies in neurology will find Aktualnosci Neurologiczne an invaluable resource, providing insights that drive advancements in the field. The journal operates from its address in Warsaw, Poland, and invites contributions from the global research community to enrich its content and impact.

Neurodegenerative Disease Management

Unlocking New Frontiers in Disease Management
Publisher: FUTURE MEDICINE LTDISSN: 1758-2024Frequency: 6 issues/year

Neurodegenerative Disease Management is a distinguished journal published by FUTURE MEDICINE LTD, focusing on the pivotal issues surrounding the management of neurodegenerative diseases. Since its inception in 2014, this journal has emerged as a significant resource within the fields of medicine and neurology, currently holding a respected position with a Q2 category ranking in Medicine (miscellaneous) and Q3 in Neurology (clinical) for 2023. With an ISSN of 1758-2024 and E-ISSN 1758-2032, the journal provides a platform for the dissemination of innovative research, clinical practices, and advancements in treatment strategies for conditions such as Alzheimer's, Parkinson's, and multiple sclerosis. The journal is particularly committed to enhancing knowledge sharing among researchers, health professionals, and students, contributing to the collective effort in combatting neurodegenerative diseases. Though not open access, its articles are meticulously curated to ensure high-quality, impactful contributions to the field, making it an essential reference for those engaged in neurology and related disciplines.

NEUROMUSCULAR DISORDERS

Exploring the intersection of genetics and neurology.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-8966Frequency: 12 issues/year

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.

Turkish Journal of Neurology

Connecting minds to unravel the complexities of the brain.
Publisher: GALENOS PUBL HOUSEISSN: 1301-062XFrequency: 4 issues/year

Turkish Journal of Neurology, published by GALENOS PUBL HOUSE, is a pivotal open-access journal established in 2004, dedicated to advancing the field of neurology. Renowned for its inclusive approach, this journal serves as a vital platform for researchers and clinicians to share their findings and insights related to neurological disorders and clinical practices, with an emphasis on enhancing the understanding of various neurological conditions affecting populations in Turkey and beyond. Although it holds a Q4 rank in Neurology (Clinical) as per the 2023 category quartiles, the journal's commitment to fostering knowledge exchange remains steadfast, aiming to bridge gaps in clinical research and practice. With an ISSN of 1301-062X and an E-ISSN of 1309-2545, it is indexed in Scopus, ranking 349 out of 400, reflecting its growing presence in the academic sphere. Located in Istanbul, Turkey, the journal invites submissions from both emerging and established researchers to contribute to its diverse content, thereby enhancing its impact on the local and international neurology community.

Journal of Clinical Neurology

Connecting Research and Practice in Neurology
Publisher: KOREAN NEUROLOGICAL ASSOCISSN: 1738-6586Frequency: 4 issues/year

The Journal of Clinical Neurology, published by the Korean Neurological Association, is a prominent open-access journal that has been disseminating crucial findings in the field of neurology since its inception in 2008. With an ISSN of 1738-6586 and an E-ISSN of 2005-5013, this journal provides a vital platform for researchers and clinicians to share innovative research, reviews, and case studies that advance understanding and treatment of neurological disorders. The journal has established its reputation, achieving a Q3 ranking in Neurology and a Q2 ranking in Clinical Neurology in 2023, placing it among the noteworthy sources in the medical community. With its open-access format since 2011, it facilitates broad dissemination of knowledge to both the scientific community and the public, supporting the journal's mission to enhance clinical practice and promote neurological health in South Korea and beyond. As of October 2023, it holds influential Scopus ranks, reflecting its impact and relevance in the ever-evolving landscape of neuroscience. Researchers, professionals, and students alike are encouraged to contribute to and engage with the ongoing discourse by submitting their work and accessing a wealth of resources through this esteemed publication.

NEUROLOGIC CLINICS

Transforming research into clinical practice.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8619Frequency: 4 issues/year

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

Archives of Neuroscience

Bridging research and clinical practice for a healthier brain.
Publisher: BRIEFLANDISSN: 2322-3944Frequency: 4 issues/year

Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.

Future Neurology

Unveiling breakthroughs in neurotherapeutics and diagnostics.
Publisher: FUTURE MEDICINE LTDISSN: 1479-6708Frequency: 4 issues/year

Future Neurology, published by Future Medicine Ltd, is an emerging peer-reviewed journal dedicated to the rapidly evolving field of neurology, with a keen focus on both clinical and translational research. Since its inception in 2007, the journal has provided a unique platform for sharing innovative findings and fostering collaboration among neurologists, neuroscientists, and healthcare professionals. Although currently categorized in the Q4 quartile for both Neurology and Clinical Neurology, Future Neurology strives to improve its impact factor by publishing high-quality research and reviews that address pressing issues in neurological health. With its commitment to disseminating knowledge, the journal serves as an essential resource for professionals and researchers seeking to stay informed about advancements in neurological science. It is particularly valuable for those looking to contribute to and engage with the latest developments in neurotherapeutics, diagnostics, and patient care strategies. The journal is indexed in major databases and is available in print and online formats, ensuring wider accessibility to its content for all stakeholders in the field.